Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vitro
Remarks:
Keratinosens
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
GLP compliance:
yes
Type of study:
activation of keratinocytes
Justification for non-LLNA method:
Alternative in vitro method recommended in first intention by ECHA.

Test material

Constituent 1
Chemical structure
Reference substance name:
2-propylvaleronitrile
EC Number:
236-338-2
EC Name:
2-propylvaleronitrile
Cas Number:
13310-75-3
Molecular formula:
C8H15N
IUPAC Name:
2-propylpentanenitrile

In vitro test system

Details on the study design:
The test article was dissolved in dimethyl sulfoxide (DMSO) to the final concentration (200 mM). Serial dilutions were then made using DMSO to obtain 12 master concentrations of the test article (0.098, 0.196, 0.391, 0.781, 1.563, 3.125, 6.25, 12.5, 25, 50, 100 and 200 mM).
The master concentrations were then further diluted 25 fold into culture medium containing serum and finally used for treatment with a further 4 fold dilution factor so that the final concentrations of test article ranged from 0.98 to 2000 μM in 1% DMSO.
Aliquots of 50 μL of each of the final concentrations were transferred to each of three luciferase plates and a single viability plate. Each plate was sealed using a plate sealer and then incubated at 37±1°C, 5% (v/v) CO2 in air, in a humidified environment for 48±1 hours.
After the 48-hour exposure period, the medium in the luciferase plates was replaced with fresh medium containing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).The plate was sealed and incubated for 4 hours at 37±1°C, 5% (v/v) CO2. The MTT medium was then removed and SDS (at 10% w/v) added per well. The plate was sealed and placed into an incubator at 37±1°C, 5% (v/v) CO2 in air and left overnight. After the overnight incubation, the plate was shaken to ensure homogeneity of the solution in the wells and then absorption read at 600 nm using a SpectraMax M2e. After the 48-hour exposure period, the cells in the viability plate were washed with phosphate buffered saline and lysis buffer for luminescence readings was added to each well. The plates were then incubated for 20 minutes at 25±2°C, loaded into the luminescence plate reader and read.

Results and discussion

Positive control results:
Luciferase activity induction obtained with the positive control was statistically significant above the threshold of 1.5 at concentrations of 8 to 64 μM in Experiment 1, at concentrations of 4 to 64 μM in Experiment 2 and at concentrations of 16 to 64 μM in Experiment 3. The EC1.5 values for the positive control were 7.99, 2.45 and 11.53 μM in Experiments 1, 2 and 3, respectively. The average induction in the three replicates for the positive control at 64 μM was 22.07, 6.59 and 17.42 in Experiments 1, 2 and 3, respectively.

In vitro / in chemico

Resultsopen allclose all
Key result
Run / experiment:
other: experiment 1
Parameter:
other: EC 1.5 (ug/mL)
Value:
805
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: I(max) 1.73
Key result
Run / experiment:
other: experiment 2
Parameter:
other: EC 1.5 (ug/mL)
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
not determinable
Remarks:
I (max) 1.15; below thre threshold of 1.5 therefore EC1.5 could not be calculated
Key result
Run / experiment:
other: experiment 3
Parameter:
other: EC 1.5 (ug/mL)
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
not determinable
Remarks:
I (max) 1.15; below thre threshold of 1.5 therefore EC1.5 could not be calculated
Other effects / acceptance of results:
Test item: The maximal fold increases (Imax) were 1.73, 1.15 and 1.16 for Experiments 1, 2 and 3, respectively. The EC1.5 value for Experiment 1 was 805 μg/mL. There were no EC1.5 values for Experiments 2 and 3 as there were no statistically significant increases in induction.

Positive control: The EC1.5 value for the positive control in Experiment 2 and the average induction at 64 μM in Experiments 1 and 3 were outside the range specified in the Protocol. These deviations from Protocol did not affect the integrity or outcome as the positive control gave a satisfactory dose response.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The test article, 2-propylvaleronitrile (CAS 13310-75-3), was considered to be negative in the ARE-Nrf2 Luciferase Test.